<SEC-DOCUMENT>0001104659-21-130769-index.html : 20211028
<SEC-HEADER>0001104659-21-130769.hdr.sgml : 20211028
<ACCEPTANCE-DATETIME>20211028092815
ACCESSION NUMBER:		0001104659-21-130769
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		21
FILED AS OF DATE:		20211028
DATE AS OF CHANGE:		20211028

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nuvectis Pharma, Inc.
		CENTRAL INDEX KEY:			0001875558
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				862405608
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-260099
		FILM NUMBER:		211355526

	BUSINESS ADDRESS:	
		STREET 1:		1 BRIDGE PLAZA, SUITE 275
		CITY:			FORT LEE
		STATE:			NJ
		ZIP:			07024
		BUSINESS PHONE:		360-837-7232

	MAIL ADDRESS:	
		STREET 1:		1 BRIDGE PLAZA, SUITE 275
		CITY:			FORT LEE
		STATE:			NJ
		ZIP:			07024
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>tm2123577-11_s1a.htm
<DESCRIPTION>S-1/A
<TEXT>
Document 1 - file: tm2123577-11_s1a.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>tm2123577d12_ex1-1.htm <DESCRIPTION>EXHIBIT 1.1 <TEXT> Document 2 - file: tm2123577d12_ex1-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.2 <SEQUENCE>3 <FILENAME>tm2123577d12_ex4-2.htm <DESCRIPTION>EXHIBIT 4.2 <TEXT> Document 3 - file: tm2123577d12_ex4-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>4 <FILENAME>tm2123577d12_ex10-2.htm <DESCRIPTION>EXHIBIT 10.2 <TEXT> Document 4 - file: tm2123577d12_ex10-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.3 <SEQUENCE>5 <FILENAME>tm2123577d12_ex10-3.htm <DESCRIPTION>EXHIBIT 10.3 <TEXT> Document 5 - file: tm2123577d12_ex10-3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.4 <SEQUENCE>6 <FILENAME>tm2123577d12_ex10-4.htm <DESCRIPTION>EXHIBIT 10.4 <TEXT> Document 6 - file: tm2123577d12_ex10-4.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>7 <FILENAME>tm2123577d12_ex23-1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 7 - file: tm2123577d12_ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>lg_nuvectispharma-4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 8 - file: lg_nuvectispharma-4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>lg_pwc-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 9 - file: lg_pwc-4c.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>10 <FILENAME>tm2123577d1-fc_1fig4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 10 - file: tm2123577d1-fc_1fig4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>11 <FILENAME>tm2123577d1-fc_2fig4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 11 - file: tm2123577d1-fc_2fig4c.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>12 <FILENAME>tm2123577d1-lc_4fig4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 12 - file: tm2123577d1-lc_4fig4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>13 <FILENAME>tm2123577d1-org_5fig4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 13 - file: tm2123577d1-org_5fig4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>14 <FILENAME>tm2123577d1-pht_6fig4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 14 - file: tm2123577d1-pht_6fig4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>15 <FILENAME>tm2123577d1-tbl_4fig4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 15 - file: tm2123577d1-tbl_4fig4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>16 <FILENAME>tm2123577d12_ex23-1img001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 16 - file: tm2123577d12_ex23-1img001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>17 <FILENAME>tm2123577d2-fc_target4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 17 - file: tm2123577d2-fc_target4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>18 <FILENAME>tm2123577d2-lc_potent4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 18 - file: tm2123577d2-lc_potent4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>19 <FILENAME>tm2123577d2-lc_tumor4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 19 - file: tm2123577d2-lc_tumor4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>20 <FILENAME>tm2123577d2-pht_inhibit4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 20 - file: tm2123577d2-pht_inhibit4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>21 <FILENAME>tm2123577d5-tbl_nuvectis4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 21 - file: tm2123577d5-tbl_nuvectis4c.jpg
</DOCUMENT> </SEC-DOCUMENT>